An infusion reaction to cetuximab.
作者信息
Waxman Elizabeth S
出版信息
Oncology (Williston Park). 2011 Apr;25(4 Suppl Nurse Ed):38-41.
PMID:25391206
Abstract
摘要
相似文献
1
An infusion reaction to cetuximab.
Oncology (Williston Park). 2011 Apr;25(4 Suppl Nurse Ed):38-41.
2
Manage infusion reactions from cetuximab.
ONS Connect. 2008 Sep;23(9):18-9.
3
A patient on targeted therapy: cetuximab.
Oncology (Williston Park). 2006 Sep;20(10 Suppl Nurse Ed):25-7.
4
Cetuximab infusion reactions: French pharmacovigilance database analysis.
J Oncol Pharm Pract. 2013 Jun;19(2):130-7. doi: 10.1177/1078155212457965. Epub 2012 Nov 15.
5
[An unexpected and severe infusion reaction induced by trastuzumab].
Farm Hosp. 2014 May 1;38(3):254-5. doi: 10.7399/fh.2014.38.3.1169.
6
Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.
J Oncol Pharm Pract. 2014 Dec;20(6):409-16. doi: 10.1177/1078155213510542. Epub 2013 Nov 14.
7
Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
Clin J Oncol Nurs. 2008 Jun;12(3):530-2. doi: 10.1188/08.CJON.530-532.
8
Desensitization to chemotherapeutic agents.
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):116-7. doi: 10.1016/j.jaip.2013.08.013.
9
Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment.
J Support Oncol. 2010 Mar-Apr;8(2):72-7.
10
Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
J Clin Oncol. 2005 Aug 1;23(22):5273-5. doi: 10.1200/JCO.2005.01.9570.
Zotero 插件